Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125
NCT03185195
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
AQX-1125 Oral Tablet
DRUG:
[14C]-AQX-1125 IV
DRUG:
[14C]-AQX-1125 Oral Solution
Sponsor
Aquinox Pharmaceuticals (Canada) Inc.
Collaborators
[object Object]